HOOKIPA Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-81.58	-64.92	-75.67	-44.08	-43.04	-16.24	-12.72
Depreciation & Amortization	3.55	3.6	4.64	4.15	3.07	0.64	0.4
Share-Based Compensation	2.35	5.04	7.64	8.66	5.57	0.87	0.77
Other Operating Activities	18.16	36.27	-2.64	-8.06	-7.33	-0.27	-0.36
Operating Cash Flow	-57.52	-20	-66.02	-39.34	-41.73	-15	-11.91
Capital Expenditures	-4.16	-5.02	-12.58	-2.37	-2	-2.15	-1.3
Investing Cash Flow	-4.16	-5.02	-12.58	-2.37	-2	-2.15	-1.3
Share Issuance / Repurchase	49.04	45.69	0.2	42.64	74.76	0.01	0
Debt Issued / Paid	-1.75	-2.85	-0.44	-1.42	-2.28	0.43	0.75
Other Financing Activities	18.38	29.43	-	32.2	37.27	6.44	58.15
Financing Cash Flow	65.67	72.27	-0.24	73.42	109.75	6.87	58.89
Exchange Rate Effect	0.09	-0.73	2.57	-2.11	-1.03	-2.51	2.49
Net Cash Flow	3.99	47.26	-78.83	31.71	66.02	-10.28	45.68
Free Cash Flow	-61.68	-25.01	-78.6	-41.71	-43.73	-17.15	-13.21
Free Cash Flow Margin	-306.44%	-175.55%	-426.05%	-212.98%	-366.19%	-224.77%	-
Free Cash Flow Per Share	-0.73	-0.46	-2.62	-1.63	-2.45	-18.75	-14.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).